UnitedHealthcare stock plunges faces backlash CEO shooting

...

Andrew Stanton

By Andrew Stanton

Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


UnitedHealth's stock plunged amid backlash stirred by the fatal shooting of UnitedHealthcare CEO Brian Thompson last week.

Nearly a week after Thompson was shot in New York City, Mayor Eric Adams confirmed that law enforcement had arrested a "strong person of interest" in Pennsylvania. They named 26-year-old Luigi Mangione as the person of interest, but he has not been formally charged with the shooting.

Thompson was shot at about 6:45 a.m. on December 4 outside the Hilton in Midtown Manhattan, and the suspected shooter is believed to have fled the scene toward Central Park. Multiple outlets reported that three shell casings recovered from the scene were emblazoned with the words "deny," "defend," and "depose," which some have suggested was a reference to a book critical of the insurance industry, Delay, Deny, Defend.

Read More on U.S.

Many Americans responded with indifference to the shooting, citing their frustrations with the health care system. Critics took to social media to share their stories of UnitedHealthcare allegedly denying their health care coverage claims, slamming the company for placing greater emphasis on their bottom line over providing quality coverage to its insurees. Others have said they would refuse to help police catch the shooter.

Several financial experts told Newsweek on Monday that the outrage fueled a drop in the value of UnitedHealth's stocks.

UnitedHealth's stock dropped more than 10 percent from Wednesday to the end of the day Friday, though the immediate news of the shooting did little to move the company's stock. The stock value did increase after news broke about the arrest Monday morning.

Newsweek reached out to UnitedHealth for comment via email.

Laura Veldkamp, a professor of finance and economics at Columbia University, told Newsweek that there are a few reasons the backlash is driving down stock value.

She said investors are likely concerned that the company's backlash could affect them if they invest in it. The debate also raises the question of whether companies should prioritize shareholder value over stakeholder value.

"If you create these bad effects for people, for the environment...you create risks. It might not show up in your profit immediately, but it creates the risks of backlash, the risks of regulation, the risks that your consumers may one day wake up and decide that we don't want to engage with a company that does this to us anymore," she said.

In the short-term, the company may not have to change much, she said, noting that the "dysfunctional" state of politics makes it unlikely the industry will face any new regulations or legislative action due to the backlash. Consumers also have less room to respond because most get their insurance through their employers.

UnitedHealthcare stock plunges faces backlash CEO shooting

...

But it might be worth it for UnitedHealth to change some of its practices, Veldkamp said.

"It's the unknown unknowns that might motivate UnitedHealtchare to try to do better, to try to serve its customers better. Maybe this drop in stock price will help convey to shareholders that they too will lose if stakeholders aren't taken into account," she said.

David Park, an associate professor of entrepreneurship at Syracuse University, told Newsweek that "events like these can cast a long shadow over a firm's perceived corporate responsibility and ethical standards."

He said media and public scrutiny may be fueling investors' concerns about whether UnitedHealth will see reduced customer loyalty, resulting in worse financial performance.

The company is also under pressure because the shooting has led to a broader debate about "systemic issues within the health insurance industry as a whole," Park said.

UnitedHealth can take several steps to rebuild trust among investors and consumers beyond just a "cosmetic public relations campaign," he said.

"The company could engage in transparent communication that outlines the root causes of the crisis and the concrete steps being taken to prevent future occurrences. Initiatives might include third-party audits of internal policies, public disclosure of enhanced security measures, or the hiring of independent experts to review and recommend improvements," he said.

Addressing concerns about broader issues, such as claims transparency, can also fix its reputation, he added.

Stephen Ciccone, an associate professor of finance at the University of New Hampshire, told Newsweek that "other insurance companies are facing similar scrutiny and have also seen declines in their stock prices, though not as dramatic as that of [UnitedHealth]."

"I believe that [UnitedHealth] and other insurance companies will take steps to address the public outcry. If they don't, consumer dissatisfaction will persist, and the industry could face increased government regulation," he said.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines